abstract |
The use of a compound of formula A or a pharmaceutically acceptable derivative thereof for the manufacture of a medicament for the treatment of pulmonary hypertension, where R1, R2, R5, R6, B, C, D and G have the meanings described herein. Pharmaceutical compositions that contain the compounds are also described. |